Home > > > > Report Detail

Global Insulin Delivery Systems Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 14-Oct-2022
No. of pages: 119
Inquire Before Buying

Report Scope

This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Insulin Delivery Systems manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Insulin Delivery Systems market. Further, it explains the major drivers and regional dynamics of the global Insulin Delivery Systems market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- Becton, Dickinson and Company

- Novo Nordisk

- Medtronic

- Sanofi

- ELI Lilly and Company

- Ypsomed Holding

- Animas Corporation

- Tandem Diabetes Care

- Insulet Corporation

- Biocon

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.

Insulin Delivery Systems Segment by Type

- Insulin Pens

- Insulin Pumps

- Insulin Syringes

Insulin Delivery Systems Segment by Application

- Homecare

- Hospitals & Clinics

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Insulin Delivery Systems market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Insulin Delivery Systems, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Insulin Delivery Systems, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Insulin Delivery Systems, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Insulin Delivery Systems sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Insulin Delivery Systems market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Insulin Delivery Systems sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Becton, Dickinson and Company, Novo Nordisk, Medtronic, Sanofi, ELI Lilly and Company, Ypsomed Holding, Animas Corporation, Tandem Diabetes Care and Insulet Corporation, etc.

Global Insulin Delivery Systems Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Insulin Delivery Systems Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Insulin Pens
1.2.3 Insulin Pumps
1.2.4 Insulin Syringes
1.3 Market Segment by Application
1.3.1 Global Insulin Delivery Systems Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Homecare
1.3.3 Hospitals & Clinics
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Insulin Delivery Systems Market Size (2017-2028)
2.1.1 Global Insulin Delivery Systems Revenue (2017-2028)
2.1.2 Global Insulin Delivery Systems Sales (2017-2028)
2.2 Global Insulin Delivery Systems Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Insulin Delivery Systems Sales by Regions (2017-2022)
2.2.2 Global Insulin Delivery Systems Revenue by Regions (2017-2022)
2.3 Global Insulin Delivery Systems Market Size Forecast by Region
2.3.1 Global Insulin Delivery Systems Sales Forecast by Region (2023-2028)
2.3.2 Global Insulin Delivery Systems Revenue Forecast by Region (2023-2028)
2.4 Global Top Insulin Delivery Systems Regions (Countries) Ranking by Market Size
2.5 Insulin Delivery Systems Market Dynamics
2.5.1 Insulin Delivery Systems Market Trends
2.5.2 Insulin Delivery Systems Market Drivers
2.5.3 Insulin Delivery Systems Market Challenges
2.5.4 Insulin Delivery Systems Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Insulin Delivery Systems Manufacturers by Sales (2017-2022)
3.1.1 Global Insulin Delivery Systems Sales by Manufacturers (2017-2022)
3.1.2 Global Insulin Delivery Systems Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Insulin Delivery Systems Sales in 2021
3.2 Global Top Manufacturers Insulin Delivery Systems by Revenue
3.2.1 Global Insulin Delivery Systems Revenue by Manufacturers (2017-2022)
3.2.2 Top Insulin Delivery Systems Manufacturers Covered: Ranking by Revenue
3.2.3 Global Insulin Delivery Systems Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Insulin Delivery Systems Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Insulin Delivery Systems as of 2021)
3.4 Global Insulin Delivery Systems Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Insulin Delivery Systems Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Insulin Delivery Systems Market
3.7 Key Manufacturers Insulin Delivery Systems Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Insulin Delivery Systems Market Size by Type
4.1 Global Insulin Delivery Systems Historic Market Review by Type (2017-2022)
4.1.1 Global Insulin Delivery Systems Sales Market Share by Type (2017-2022)
4.1.2 Global Insulin Delivery Systems Revenue Market Share by Type (2017-2022)
4.1.3 Insulin Delivery Systems Price by Type (2017-2022)
4.2 Global Insulin Delivery Systems Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Insulin Delivery Systems Sales Forecast by Type (2023-2028)
4.2.2 Global Insulin Delivery Systems Revenue Forecast by Type (2023-2028)
4.2.3 Insulin Delivery Systems Price Forecast by Type (2023-2028)
5 Global Insulin Delivery Systems Market Size by Application
5.1 Global Insulin Delivery Systems Historic Market Review by Application (2017-2022)
5.1.1 Global Insulin Delivery Systems Sales Market Share by Application (2017-2022)
5.1.2 Global Insulin Delivery Systems Revenue Market Share by Application (2017-2022)
5.1.3 Insulin Delivery Systems Price by Application (2017-2022)
5.2 Global Insulin Delivery Systems Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Insulin Delivery Systems Sales Forecast by Application (2023-2028)
5.2.2 Global Insulin Delivery Systems Revenue Forecast by Application (2023-2028)
5.2.3 Insulin Delivery Systems Price Forecast by Application (2023-2028)
6 North America
6.1 North America Insulin Delivery Systems Sales Breakdown by Company
6.1.1 North America Insulin Delivery Systems Sales by Company (2017-2022)
6.1.2 North America Insulin Delivery Systems Revenue by Company (2017-2022)
6.2 North America Insulin Delivery Systems Market Size by Type
6.2.1 North America Insulin Delivery Systems Sales by Type (2017-2028)
6.2.2 North America Insulin Delivery Systems Revenue by Type (2017-2028)
6.3 North America Insulin Delivery Systems Market Size by Application
6.3.1 North America Insulin Delivery Systems Sales by Application (2017-2028)
6.3.2 North America Insulin Delivery Systems Revenue by Application (2017-2028)
6.4 North America Insulin Delivery Systems Market Size by Country
6.4.1 North America Insulin Delivery Systems Sales by Country (2017-2028)
6.4.2 North America Insulin Delivery Systems Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Insulin Delivery Systems Sales Breakdown by Company
7.1.1 Europe Insulin Delivery Systems Sales by Company (2017-2022)
7.1.2 Europe Insulin Delivery Systems Revenue by Company (2017-2022)
7.2 Europe Insulin Delivery Systems Market Size by Type
7.2.1 Europe Insulin Delivery Systems Sales by Type (2017-2028)
7.2.2 Europe Insulin Delivery Systems Revenue by Type (2017-2028)
7.3 Europe Insulin Delivery Systems Market Size by Application
7.3.1 Europe Insulin Delivery Systems Sales by Application (2017-2028)
7.3.2 Europe Insulin Delivery Systems Revenue by Application (2017-2028)
7.4 Europe Insulin Delivery Systems Market Size by Country
7.4.1 Europe Insulin Delivery Systems Sales by Country (2017-2028)
7.4.2 Europe Insulin Delivery Systems Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Insulin Delivery Systems Sales Breakdown by Company
8.1.1 Asia Pacific Insulin Delivery Systems Sales by Company (2017-2022)
8.1.2 Asia Pacific Insulin Delivery Systems Revenue by Company (2017-2022)
8.2 Asia Pacific Insulin Delivery Systems Market Size by Type
8.2.1 Asia Pacific Insulin Delivery Systems Sales by Type (2017-2028)
8.2.2 Asia Pacific Insulin Delivery Systems Revenue by Type (2017-2028)
8.3 Asia Pacific Insulin Delivery Systems Market Size by Application
8.3.1 Asia Pacific Insulin Delivery Systems Sales by Application (2017-2028)
8.3.2 Asia Pacific Insulin Delivery Systems Revenue by Application (2017-2028)
8.4 Asia Pacific Insulin Delivery Systems Market Size by Region
8.4.1 Asia Pacific Insulin Delivery Systems Sales by Region
8.4.2 Asia Pacific Insulin Delivery Systems Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Insulin Delivery Systems Sales Breakdown by Company
9.1.1 Latin America Insulin Delivery Systems Sales by Company (2017-2022)
9.1.2 Latin America Insulin Delivery Systems Revenue by Company (2017-2022)
9.2 Latin America Insulin Delivery Systems Market Size by Type
9.2.1 Latin America Insulin Delivery Systems Sales by Type (2017-2028)
9.2.2 Latin America Insulin Delivery Systems Revenue by Type (2017-2028)
9.3 Latin America Insulin Delivery Systems Market Size by Application
9.3.1 Latin America Insulin Delivery Systems Sales by Application (2017-2028)
9.3.2 Latin America Insulin Delivery Systems Revenue by Application (2017-2028)
9.4 Latin America Insulin Delivery Systems Market Size by Country
9.4.1 Latin America Insulin Delivery Systems Sales by Country (2017-2028)
9.4.2 Latin America Insulin Delivery Systems Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Insulin Delivery Systems Sales Breakdown by Company
10.1.1 Middle East and Africa Insulin Delivery Systems Sales by Company (2017-2022)
10.1.2 Middle East and Africa Insulin Delivery Systems Revenue by Company (2017-2022)
10.2 Middle East and Africa Insulin Delivery Systems Market Size by Type
10.2.1 Middle East and Africa Insulin Delivery Systems Sales by Type (2017-2028)
10.2.2 Middle East and Africa Insulin Delivery Systems Revenue by Type (2017-2028)
10.3 Middle East and Africa Insulin Delivery Systems Market Size by Application
10.3.1 Middle East and Africa Insulin Delivery Systems Sales by Application (2017-2028)
10.3.2 Middle East and Africa Insulin Delivery Systems Revenue by Application (2017-2028)
10.4 Middle East and Africa Insulin Delivery Systems Market Size by Country
10.4.1 Middle East and Africa Insulin Delivery Systems Sales by Country (2017-2028)
10.4.2 Middle East and Africa Insulin Delivery Systems Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 U.A.E
11 Company Profiles
11.1 Becton, Dickinson and Company
11.1.1 Becton, Dickinson and Company Corporation Information
11.1.2 Becton, Dickinson and Company Overview
11.1.3 Becton, Dickinson and Company Insulin Delivery Systems Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 Becton, Dickinson and Company Insulin Delivery Systems Products and Services
11.1.5 Becton, Dickinson and Company Insulin Delivery Systems SWOT Analysis
11.1.6 Becton, Dickinson and Company Recent Developments
11.2 Novo Nordisk
11.2.1 Novo Nordisk Corporation Information
11.2.2 Novo Nordisk Overview
11.2.3 Novo Nordisk Insulin Delivery Systems Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Novo Nordisk Insulin Delivery Systems Products and Services
11.2.5 Novo Nordisk Insulin Delivery Systems SWOT Analysis
11.2.6 Novo Nordisk Recent Developments
11.3 Medtronic
11.3.1 Medtronic Corporation Information
11.3.2 Medtronic Overview
11.3.3 Medtronic Insulin Delivery Systems Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Medtronic Insulin Delivery Systems Products and Services
11.3.5 Medtronic Insulin Delivery Systems SWOT Analysis
11.3.6 Medtronic Recent Developments
11.4 Sanofi
11.4.1 Sanofi Corporation Information
11.4.2 Sanofi Overview
11.4.3 Sanofi Insulin Delivery Systems Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Sanofi Insulin Delivery Systems Products and Services
11.4.5 Sanofi Insulin Delivery Systems SWOT Analysis
11.4.6 Sanofi Recent Developments
11.5 ELI Lilly and Company
11.5.1 ELI Lilly and Company Corporation Information
11.5.2 ELI Lilly and Company Overview
11.5.3 ELI Lilly and Company Insulin Delivery Systems Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 ELI Lilly and Company Insulin Delivery Systems Products and Services
11.5.5 ELI Lilly and Company Insulin Delivery Systems SWOT Analysis
11.5.6 ELI Lilly and Company Recent Developments
11.6 Ypsomed Holding
11.6.1 Ypsomed Holding Corporation Information
11.6.2 Ypsomed Holding Overview
11.6.3 Ypsomed Holding Insulin Delivery Systems Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 Ypsomed Holding Insulin Delivery Systems Products and Services
11.6.5 Ypsomed Holding Insulin Delivery Systems SWOT Analysis
11.6.6 Ypsomed Holding Recent Developments
11.7 Animas Corporation
11.7.1 Animas Corporation Corporation Information
11.7.2 Animas Corporation Overview
11.7.3 Animas Corporation Insulin Delivery Systems Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 Animas Corporation Insulin Delivery Systems Products and Services
11.7.5 Animas Corporation Insulin Delivery Systems SWOT Analysis
11.7.6 Animas Corporation Recent Developments
11.8 Tandem Diabetes Care
11.8.1 Tandem Diabetes Care Corporation Information
11.8.2 Tandem Diabetes Care Overview
11.8.3 Tandem Diabetes Care Insulin Delivery Systems Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 Tandem Diabetes Care Insulin Delivery Systems Products and Services
11.8.5 Tandem Diabetes Care Insulin Delivery Systems SWOT Analysis
11.8.6 Tandem Diabetes Care Recent Developments
11.9 Insulet Corporation
11.9.1 Insulet Corporation Corporation Information
11.9.2 Insulet Corporation Overview
11.9.3 Insulet Corporation Insulin Delivery Systems Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.9.4 Insulet Corporation Insulin Delivery Systems Products and Services
11.9.5 Insulet Corporation Insulin Delivery Systems SWOT Analysis
11.9.6 Insulet Corporation Recent Developments
11.10 Biocon
11.10.1 Biocon Corporation Information
11.10.2 Biocon Overview
11.10.3 Biocon Insulin Delivery Systems Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.10.4 Biocon Insulin Delivery Systems Products and Services
11.10.5 Biocon Insulin Delivery Systems SWOT Analysis
11.10.6 Biocon Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Insulin Delivery Systems Value Chain Analysis
12.2 Insulin Delivery Systems Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Insulin Delivery Systems Production Mode & Process
12.4 Insulin Delivery Systems Sales and Marketing
12.4.1 Insulin Delivery Systems Sales Channels
12.4.2 Insulin Delivery Systems Distributors
12.5 Insulin Delivery Systems Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Insulin Delivery Systems Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Insulin Pens
Table 3. Major Manufacturers of Insulin Pumps
Table 4. Major Manufacturers of Insulin Syringes
Table 5. Global Insulin Delivery Systems Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Insulin Delivery Systems Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 7. Global Insulin Delivery Systems Sales by Region (2017-2022) & (K Units)
Table 8. Global Insulin Delivery Systems Sales Market Share by Region (2017-2022)
Table 9. Global Insulin Delivery Systems Revenue by Region (2017-2022) & (US$ Million)
Table 10. Global Insulin Delivery Systems Revenue Market Share by Region (2017-2022)
Table 11. Global Insulin Delivery Systems Sales Forecast by Region (2023-2028) & (K Units)
Table 12. Global Insulin Delivery Systems Sales Market Share Forecast by Region (2023-2028)
Table 13. Global Insulin Delivery Systems Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 14. Global Insulin Delivery Systems Revenue Market Share Forecast by Region (2023-2028)
Table 15. Top Insulin Delivery Systems Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 16. Insulin Delivery Systems Market Trends
Table 17. Insulin Delivery Systems Market Drivers
Table 18. Insulin Delivery Systems Market Challenges
Table 19. Insulin Delivery Systems Market Restraints
Table 20. Global Insulin Delivery Systems Sales by Manufacturers (2017-2022) & (K Units)
Table 21. Global Insulin Delivery Systems Sales Share by Manufacturers (2017-2022)
Table 22. Global Insulin Delivery Systems Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 23. Ranking of Global Top Insulin Delivery Systems Manufacturers by Revenue (US$ Million) in 2021
Table 24. Insulin Delivery Systems Revenue Share by Manufacturers (2017-2022)
Table 25. Global Insulin Delivery Systems Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 26. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Insulin Delivery Systems as of 2021)
Table 27. Key Manufacturers Insulin Delivery Systems Average Selling Price (ASP) & (2017-2022) & (USD/Unit)
Table 28. Key Manufacturers Insulin Delivery Systems Plants/Factories Distribution
Table 29. Key Manufacturers Insulin Delivery Systems Area Served
Table 30. Date of Key Manufacturers Enter into Insulin Delivery Systems Market
Table 31. Key Manufacturers Insulin Delivery Systems Product Type
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Insulin Delivery Systems Sales (K Units) by Type (2017-2022)
Table 34. Global Insulin Delivery Systems Sales Share by Type (2017-2022)
Table 35. Global Insulin Delivery Systems Revenue (US$ Million) Market Share by Type (2017-2022)
Table 36. Global Insulin Delivery Systems Price (K Units) by Type (2017-2022)
Table 37. Global Insulin Delivery Systems Sales (K Units) by Type (2023-2028)
Table 38. Global Insulin Delivery Systems Sales Share by Type (2023-2028)
Table 39. Global Insulin Delivery Systems Revenue (US$ Million) Market Share by Type (2023-2028)
Table 40. Global Insulin Delivery Systems Revenue Share by Type (2023-2028)
Table 41. Global Insulin Delivery Systems Price (K Units) by Type (2023-2028)
Table 42. Global Insulin Delivery Systems Sales (K Units) by Application (2017-2022)
Table 43. Global Insulin Delivery Systems Sales Share by Application (2017-2022)
Table 44. Global Insulin Delivery Systems Revenue (US$ Million) Market Share by Application (2017-2022)
Table 45. Global Insulin Delivery Systems Price (K Units) by Application (2017-2022)
Table 46. Global Insulin Delivery Systems Sales (K Units) by Application (2023-2028)
Table 47. Global Insulin Delivery Systems Sales Share by Application (2023-2028)
Table 48. Global Insulin Delivery Systems Revenue (US$ Million) Market Share by Application (2023-2028)
Table 49. Global Insulin Delivery Systems Revenue Share by Application (2023-2028)
Table 50. Global Insulin Delivery Systems Price (K Units) by Application (2023-2028)
Table 51. North America Insulin Delivery Systems Sales by Company (2017-2022) & (K Units)
Table 52. North America Insulin Delivery Systems Sales Market Share by Company (2017-2022)
Table 53. North America Insulin Delivery Systems Revenue by Company (2017-2022) & (US$ Million)
Table 54. North America Insulin Delivery Systems Revenue Market Share by Company (2017-2022)
Table 55. North America Insulin Delivery Systems Sales by Type (2017-2022) & (K Units)
Table 56. North America Insulin Delivery Systems Sales by Type (2023-2028) & (K Units)
Table 57. North America Insulin Delivery Systems Revenue by Type (2017-2022) & (US$ Million)
Table 58. North America Insulin Delivery Systems Revenue by Type (2023-2028) & (US$ Million)
Table 59. North America Insulin Delivery Systems Sales by Application (2017-2022) & (K Units)
Table 60. North America Insulin Delivery Systems Sales by Application (2023-2028) & (K Units)
Table 61. North America Insulin Delivery Systems Revenue by Application (2017-2022) & (US$ Million)
Table 62. North America Insulin Delivery Systems Revenue by Application (2023-2028) & (US$ Million)
Table 63. North America Insulin Delivery Systems Sales by Country (2017-2022) & (K Units)
Table 64. North America Insulin Delivery Systems Sales by Country (2023-2028) & (K Units)
Table 65. North America Insulin Delivery Systems Revenue by Country (2017-2022) & (US$ Million)
Table 66. North America Insulin Delivery Systems Revenue by Country (2023-2028) & (US$ Million)
Table 67. Europe Insulin Delivery Systems Sales by Company (2017-2022) & (K Units)
Table 68. Europe Insulin Delivery Systems Sales Market Share by Company (2017-2022)
Table 69. Europe Insulin Delivery Systems Revenue by Company (2017-2022) & (US$ Million)
Table 70. Europe Insulin Delivery Systems Revenue Market Share by Company (2017-2022)
Table 71. Europe Insulin Delivery Systems Sales by Type (2017-2022) & (K Units)
Table 72. Europe Insulin Delivery Systems Sales by Type (2023-2028) & (K Units)
Table 73. Europe Insulin Delivery Systems Revenue by Type (2017-2022) & (US$ Million)
Table 74. Europe Insulin Delivery Systems Revenue by Type (2023-2028) & (US$ Million)
Table 75. Europe Insulin Delivery Systems Sales by Application (2017-2022) & (K Units)
Table 76. Europe Insulin Delivery Systems Sales by Application (2023-2028) & (K Units)
Table 77. Europe Insulin Delivery Systems Revenue by Application (2017-2022) & (US$ Million)
Table 78. Europe Insulin Delivery Systems Revenue by Application (2023-2028) & (US$ Million)
Table 79. Europe Insulin Delivery Systems Sales by Country (2017-2022) & (K Units)
Table 80. Europe Insulin Delivery Systems Sales by Country (2023-2028) & (K Units)
Table 81. Europe Insulin Delivery Systems Revenue by Country (2017-2022) & (US$ Million)
Table 82. Europe Insulin Delivery Systems Revenue by Country (2023-2028) & (US$ Million)
Table 83. Asia Pacific Insulin Delivery Systems Sales by Company (2017-2022) & (K Units)
Table 84. Asia Pacific Insulin Delivery Systems Sales Market Share by Company (2017-2022)
Table 85. Asia Pacific Insulin Delivery Systems Revenue by Company (2017-2022) & (US$ Million)
Table 86. Asia Pacific Insulin Delivery Systems Revenue Market Share by Company (2017-2022)
Table 87. Asia Pacific Insulin Delivery Systems Sales by Type (2017-2022) & (K Units)
Table 88. Asia Pacific Insulin Delivery Systems Sales by Type (2023-2028) & (K Units)
Table 89. Asia Pacific Insulin Delivery Systems Revenue by Type (2017-2022) & (US$ Million)
Table 90. Asia Pacific Insulin Delivery Systems Revenue by Type (2023-2028) & (US$ Million)
Table 91. Asia Pacific Insulin Delivery Systems Sales by Application (2017-2022) & (K Units)
Table 92. Asia Pacific Insulin Delivery Systems Sales by Application (2023-2028) & (K Units)
Table 93. Asia Pacific Insulin Delivery Systems Revenue by Application (2017-2022) & (US$ Million)
Table 94. Asia Pacific Insulin Delivery Systems Revenue by Application (2023-2028) & (US$ Million)
Table 95. Asia Pacific Insulin Delivery Systems Sales by Region (2017-2022) & (K Units)
Table 96. Asia Pacific Insulin Delivery Systems Sales by Region (2023-2028) & (K Units)
Table 97. Asia Pacific Insulin Delivery Systems Revenue by Region (2017-2022) & (US$ Million)
Table 98. Asia Pacific Insulin Delivery Systems Revenue by Region (2023-2028) & (US$ Million)
Table 99. Latin America Insulin Delivery Systems Sales by Company (2017-2022) & (K Units)
Table 100. Latin America Insulin Delivery Systems Sales Market Share by Company (2017-2022)
Table 101. Latin America Insulin Delivery Systems Revenue by Company (2017-2022) & (US$ Million)
Table 102. Latin America Insulin Delivery Systems Revenue Market Share by Company (2017-2022)
Table 103. Latin America Insulin Delivery Systems Sales by Type (2017-2022) & (K Units)
Table 104. Latin America Insulin Delivery Systems Sales by Type (2023-2028) & (K Units)
Table 105. Latin America Insulin Delivery Systems Revenue by Type (2017-2022) & (US$ Million)
Table 106. Latin America Insulin Delivery Systems Revenue by Type (2023-2028) & (US$ Million)
Table 107. Latin America Insulin Delivery Systems Sales by Application (2017-2022) & (K Units)
Table 108. Latin America Insulin Delivery Systems Sales by Application (2023-2028) & (K Units)
Table 109. Latin America Insulin Delivery Systems Revenue by Application (2017-2022) & (US$ Million)
Table 110. Latin America Insulin Delivery Systems Revenue by Application (2023-2028) & (US$ Million)
Table 111. Latin America Insulin Delivery Systems Sales by Country (2017-2022) & (K Units)
Table 112. Latin America Insulin Delivery Systems Sales by Country (2023-2028) & (K Units)
Table 113. Latin America Insulin Delivery Systems Revenue by Country (2017-2022) & (US$ Million)
Table 114. Latin America Insulin Delivery Systems Revenue by Country (2023-2028) & (US$ Million)
Table 115. Middle East and Africa Insulin Delivery Systems Sales by Company (2017-2022) & (K Units)
Table 116. Middle East and Africa Insulin Delivery Systems Sales Market Share by Company (2017-2022)
Table 117. Middle East and Africa Insulin Delivery Systems Revenue by Company (2017-2022) & (US$ Million)
Table 118. Middle East and Africa Insulin Delivery Systems Revenue Market Share by Company (2017-2022)
Table 119. Middle East and Africa Insulin Delivery Systems Sales by Type (2017-2022) & (K Units)
Table 120. Middle East and Africa Insulin Delivery Systems Sales by Type (2023-2028) & (K Units)
Table 121. Middle East and Africa Insulin Delivery Systems Revenue by Type (2017-2022) & (US$ Million)
Table 122. Middle East and Africa Insulin Delivery Systems Revenue by Type (2023-2028) & (US$ Million)
Table 123. Middle East and Africa Insulin Delivery Systems Sales by Application (2017-2022) & (K Units)
Table 124. Middle East and Africa Insulin Delivery Systems Sales by Application (2023-2028) & (K Units)
Table 125. Middle East and Africa Insulin Delivery Systems Revenue by Application (2017-2022) & (US$ Million)
Table 126. Middle East and Africa Insulin Delivery Systems Revenue by Application (2023-2028) & (US$ Million)
Table 127. Middle East and Africa Insulin Delivery Systems Sales by Country (2017-2022) & (K Units)
Table 128. Middle East and Africa Insulin Delivery Systems Sales by Country (2023-2028) & (K Units)
Table 129. Middle East and Africa Insulin Delivery Systems Revenue by Country (2017-2022) & (US$ Million)
Table 130. Middle East and Africa Insulin Delivery Systems Revenue by Country (2023-2028) & (US$ Million)
Table 131. Becton, Dickinson and Company Corporation Information
Table 132. Becton, Dickinson and Company Description and Overview
Table 133. Becton, Dickinson and Company Insulin Delivery Systems Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 134. Becton, Dickinson and Company Insulin Delivery Systems Product and Services
Table 135. Becton, Dickinson and Company Insulin Delivery Systems SWOT Analysis
Table 136. Becton, Dickinson and Company Recent Developments
Table 137. Novo Nordisk Corporation Information
Table 138. Novo Nordisk Description and Overview
Table 139. Novo Nordisk Insulin Delivery Systems Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 140. Novo Nordisk Insulin Delivery Systems Product and Services
Table 141. Novo Nordisk Insulin Delivery Systems SWOT Analysis
Table 142. Novo Nordisk Recent Developments
Table 143. Medtronic Corporation Information
Table 144. Medtronic Description and Overview
Table 145. Medtronic Insulin Delivery Systems Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 146. Medtronic Insulin Delivery Systems Product and Services
Table 147. Medtronic Insulin Delivery Systems SWOT Analysis
Table 148. Medtronic Recent Developments
Table 149. Sanofi Corporation Information
Table 150. Sanofi Description and Overview
Table 151. Sanofi Insulin Delivery Systems Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 152. Sanofi Insulin Delivery Systems Product and Services
Table 153. Sanofi Insulin Delivery Systems SWOT Analysis
Table 154. Sanofi Recent Developments
Table 155. ELI Lilly and Company Corporation Information
Table 156. ELI Lilly and Company Description and Overview
Table 157. ELI Lilly and Company Insulin Delivery Systems Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 158. ELI Lilly and Company Insulin Delivery Systems Product and Services
Table 159. ELI Lilly and Company Insulin Delivery Systems SWOT Analysis
Table 160. ELI Lilly and Company Recent Developments
Table 161. Ypsomed Holding Corporation Information
Table 162. Ypsomed Holding Description and Overview
Table 163. Ypsomed Holding Insulin Delivery Systems Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 164. Ypsomed Holding Insulin Delivery Systems Product and Services
Table 165. Ypsomed Holding Insulin Delivery Systems SWOT Analysis
Table 166. Ypsomed Holding Recent Developments
Table 167. Animas Corporation Corporation Information
Table 168. Animas Corporation Description and Overview
Table 169. Animas Corporation Insulin Delivery Systems Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 170. Animas Corporation Insulin Delivery Systems Product and Services
Table 171. Animas Corporation Insulin Delivery Systems SWOT Analysis
Table 172. Animas Corporation Recent Developments
Table 173. Tandem Diabetes Care Corporation Information
Table 174. Tandem Diabetes Care Description and Overview
Table 175. Tandem Diabetes Care Insulin Delivery Systems Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 176. Tandem Diabetes Care Insulin Delivery Systems Product and Services
Table 177. Tandem Diabetes Care Insulin Delivery Systems SWOT Analysis
Table 178. Tandem Diabetes Care Recent Developments
Table 179. Insulet Corporation Corporation Information
Table 180. Insulet Corporation Description and Overview
Table 181. Insulet Corporation Insulin Delivery Systems Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 182. Insulet Corporation Insulin Delivery Systems Product and Services
Table 183. Insulet Corporation Insulin Delivery Systems SWOT Analysis
Table 184. Insulet Corporation Recent Developments
Table 185. Biocon Corporation Information
Table 186. Biocon Description and Overview
Table 187. Biocon Insulin Delivery Systems Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 188. Biocon Insulin Delivery Systems Product and Services
Table 189. Biocon Insulin Delivery Systems SWOT Analysis
Table 190. Biocon Recent Developments
Table 191. Key Raw Materials Lists
Table 192. Raw Materials Key Suppliers Lists
Table 193. Insulin Delivery Systems Distributors List
Table 194. Insulin Delivery Systems Customers List
Table 195. Research Programs/Design for This Report
Table 196. Key Data Information from Secondary Sources
Table 197. Key Data Information from Primary Sources
List of Figures
Figure 1. Insul
  • Global Non-Invasive Glucose Meter Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 79
    This report studies The Non-Invasive Glucose Meter market. Noninvasive glucose monitoring refers to The measurement of blood glucose levels (required by people with diabetes to prevent both chronic and acute complications from The disease) without drawing blood, puncturing The skin, or causing pain or trauma. The global Non-Invasive Glucose Meter market was valued at US$ 179.5 million in 2023 and is anticipated to reach US$ 271.2 million by 2030, witnessing a CAGR of 6.0% during The......
  • Global Glucose Meter Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 106
    Glucose Meter is a medical device for determining The approximate concentration of glucose in The blood. It can also be a strip of glucose paper dipped into a substance and measured to The glucose chart. It is a key element of home blood glucose monitoring (HBGM) by people with diabetes mellitus or hypoglycemia. A small drop of blood, obtained by pricking The skin with a lancet, is placed on a disposable test strip that The meter reads and uses to calculate The blood glucose level. The meter the......
  • Global Blood Glucose Testing Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 101
    Blood glucose testing, also known as blood glucose monitoring, is one of The main tools involved in controlling diabetes. Blood glucose testing is The process used to measure The concentration of glucose in your blood. Blood glucose testing can be carried out at home using a blood glucose meter. A blood test involves pricking your finger with a small needle called a lancet, drawing a drop of blood from The finger and applying it to a test strip that has been engaged into a blood gluc......
  • Global Glucose Biosensors Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 139
    According to our LPI (LP Information) latest study, the global Glucose Biosensors market size was valued at US$ 3249.7 million in 2023. With growing demand in downstream market, the Glucose Biosensors is forecast to a readjusted size of US$ 3620.7 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global Glucose Biosensors market. Glucose Biosensors are expected to show stable growth in the future market. However, product ......
  • Global Artificial Pancreas Devices Systems Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 100
    According to our LPI (LP Information) latest study, the global Artificial Pancreas Devices Systems market size was valued at US$ 87 million in 2023. With growing demand in downstream market, the Artificial Pancreas Devices Systems is forecast to a readjusted size of US$ 199.2 million by 2030 with a CAGR of 12.6% during review period. The research report highlights the growth potential of the global Artificial Pancreas Devices Systems market. Artificial Pancreas Devices Systems are expect......
  • Global Blood Glucose Testing Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 130
    According to our LPI (LP Information) latest study, the global Blood Glucose Testing market size was valued at US$ 10710 million in 2023. With growing demand in downstream market, the Blood Glucose Testing is forecast to a readjusted size of US$ 13370 million by 2030 with a CAGR of 3.2% during review period. The research report highlights the growth potential of the global Blood Glucose Testing market. Blood Glucose Testing are expected to show stable growth in the future market. However......
  • Global Lancing Devices Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 117
    According to our LPI (LP Information) latest study, the global Lancing Devices market size was valued at US$ 315 million in 2023. With growing demand in downstream market, the Lancing Devices is forecast to a readjusted size of US$ 439.6 million by 2030 with a CAGR of 4.9% during review period. The research report highlights the growth potential of the global Lancing Devices market. Lancing Devices are expected to show stable growth in the future market. However, product differentiation,......
  • Global Non-Invasive Glucose Meter Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Non-Invasive Glucose Meter market size was valued at US$ 175.6 million in 2023. With growing demand in downstream market, the Non-Invasive Glucose Meter is forecast to a readjusted size of US$ 268 million by 2030 with a CAGR of 6.2% during review period. The research report highlights the growth potential of the global Non-Invasive Glucose Meter market. Non-Invasive Glucose Meter are expected to show stable growth in the futu......
  • Global Glucose Meter Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131
    According to our LPI (LP Information) latest study, the global Glucose Meter market size was valued at US$ 1258 million in 2023. With growing demand in downstream market, the Glucose Meter is forecast to a readjusted size of US$ 1959.5 million by 2030 with a CAGR of 6.5% during review period. The research report highlights the growth potential of the global Glucose Meter market. Glucose Meter are expected to show stable growth in the future market. However, product differentiation, reduc......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs